Payden & Rygel’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q3 | – | Sell |
-1,680
| Closed | -$87K | – | 152 |
|
|
2015
Q2 | $87K | Hold |
1,680
| – | – | 0.01% | 96 |
|
|
2015
Q1 | $97K | Hold |
1,680
| – | – | 0.01% | 97 |
|
|
2014
Q4 | $90K | Hold |
1,680
| – | – | 0.02% | 92 |
|
|
2014
Q3 | $97K | Sell |
1,680
-50,240
| -97% | -$2.9M | 0.02% | 89 |
|
|
2014
Q2 | $3.47M | Buy |
51,920
+17,920
| +53% | +$1.2M | 0.88% | 49 |
|
|
2014
Q1 | $2.27M | Hold |
34,000
| – | – | 0.88% | 52 |
|
|
2013
Q4 | $2.27M | Hold |
34,000
| – | – | 0.77% | 50 |
|
|
2013
Q3 | $2.13M | Sell |
34,000
-39,920
| -54% | -$2.5M | 0.76% | 52 |
|
|
2013
Q2 | $4.62M | Buy |
+73,920
| New | +$4.62M | 1.8% | 16 |
|